Show simple item record

dc.contributor.authorSeppala, L J
dc.contributor.authorvan der Velde, N
dc.contributor.authorMasud, T
dc.contributor.authorBlain, H
dc.contributor.authorPetrovic, M
dc.contributor.authorvan der Cammen, T J
dc.contributor.authorSzczerbińska, K
dc.contributor.authorHartikainen, S
dc.contributor.authorKenny, R A
dc.contributor.authorRyg, J
dc.contributor.authorEklund, P
dc.contributor.authorTopinková, E
dc.contributor.authorMair, A
dc.contributor.authorLaflamme, L
dc.contributor.authorThaler, H
dc.contributor.authorBahat, G
dc.contributor.authorGutiérrez-Valencia, M
dc.contributor.authorCaballero-Mora, M A
dc.contributor.authorLandi, F
dc.contributor.authorEmmelot-Vonk, M H
dc.contributor.authorCherubini, A
dc.contributor.authorBaeyens, J P
dc.contributor.authorCorrea-Pérez, A
dc.contributor.authorGudmundsson, A
dc.contributor.authorMarengoni, A
dc.contributor.authorO'Mahony, D
dc.contributor.authorParekh, N
dc.contributor.authorPisa, F E
dc.contributor.authorRajkumar, C
dc.contributor.authorWehling, M
dc.contributor.authorZiere, G
dc.date.accessioned2019-05-31T14:21:34Z
dc.date.available2019-05-31T14:21:34Z
dc.date.issued2019-04
dc.date.submitted2019-05
dc.identifier.citationEuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research. 2019, 36(4):299-307 Drugs Agingen_US
dc.identifier.citationThis article is co-published in the journals Drugs & Aging [https ://doi.org/10.1007/s40266-018-0622-7] and European Geriatric Medicine [https://doi.org/10.1007/s41999-019-00162-8]
dc.identifier.issn1179-1969
dc.identifier.pmid30741371
dc.identifier.doi10.1007/s40266-018-0622-7
dc.identifier.urihttp://hdl.handle.net/2336/620921
dc.descriptionTo access publisher's full text version of this article click on the hyperlink belowen_US
dc.description.abstractFalls are a major public health concern in the older population, and certain medication classes are a significant risk factor for falls. However, knowledge is lacking among both physicians and older people, including caregivers, concerning the role of medication as a risk factor. In the present statement, the European Geriatric Medicine Society (EuGMS) Task and Finish group on fall-risk-increasing drugs (FRIDs), in collaboration with the EuGMS Special Interest group on Pharmacology and the European Union of Medical Specialists (UEMS) Geriatric Medicine Section, outlines its position regarding knowledge dissemination on medication-related falls in older people across Europe. The EuGMS Task and Finish group is developing educational materials to facilitate knowledge dissemination for healthcare professionals and older people. In addition, steps in primary prevention through judicious prescribing, deprescribing of FRIDs (withdrawal and dose reduction), and gaps in current research are outlined in this position paper.en_US
dc.description.sponsorshipClementine Brigitta Maria Dalderup fund, Amsterdam University funden_US
dc.language.isoenen_US
dc.publisherAdis Internationalen_US
dc.relation.urlhttps://link.springer.com/article/10.1007%2Fs40266-018-0622-7en_US
dc.subjectAldraðiren_US
dc.subjectBylturen_US
dc.subjectLyfjagjöfen_US
dc.subject.meshDrug-Related Side Effects and Adverse Reactionsen_US
dc.subject.meshPrescription Drugsen_US
dc.subject.meshFrail Elderlyen_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 and overen_US
dc.subject.meshAccidental Falls
dc.titleEuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.en_US
dc.typeArticleen_US
dc.contributor.department1 Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. 2 Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. n.vandervelde@amc.uva.nl. 3 Nottingham University Hospitals NHS Trust, Nottingham, UK. 4 Department of Internal Medicine and Geriatrics, University Hospital of Montpellier, Montpellier University, Euromov, France. 5 Department of Internal Medicine (Geriatrics), Ghent University, Ghent, Belgium. 6 Faculty of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands. 7 Unit for Research on Aging Society, Department of Sociology of Medicine, Epidemiology and Preventive Medicine Chair, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland. 8 School of Pharmacy, University of Eastern Finland, Kuopio, Finland. 9 The Irish Longitudinal Study on Ageing (TILDA), Trinity College Dublin, Dublin 2, Ireland. 10 Department of Medical Gerontology, School of Medicine, Trinity College Dublin, Dublin 2, Ireland. 11 Falls and Syncope Unit, Mercer's Institute for Successful Ageing, St. James's Hospital, Dublin 8, Ireland. 12 Department of Geriatric Medicine, Odense University Hospital, Odense, Denmark. 13 Geriatric Research Unit, Department of Clinical Research, University of Southern Denmark, Odense, Denmark. 14 Department of Computing Science, Umeå University, Umeå, Sweden. 15 Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. 16 Faculty of Health and Social Sciences, South Bohemian University, Česke Budějovice, Czech Republic. 17 Effective Prescribing and Therapeutics, Health and Social Care Directorate, Scottish Government, Edinburgh, Scotland, UK. 18 Department of Public Health Sciences, Karolinska Institutet, Tomtebodavägen 18A, Widerströmska huset, 17177, Stockholm, Sweden. 19 Trauma Center Wien-Meidling, Kundratstrasse 37, 1120, Vienna, Austria. 20 Istanbul Medical School, Department of Internal Medicine, Division of Geriatrics, Istanbul University, Capa, 34093, Istanbul, Turkey. 21 Department of Health Sciences, Public University of Navarra (UPNA), Avda, Barañain s/n, 31008, Pamplona, Spain. 22 Servicio de Geriatría, Hospital Universitario de Getafe and CIBER de Fragilidad y Envejecimiento Saludable, Getafe, Madrid, Spain. 23 Department of Gerontology, Neuroscience and Orthopedics, Catholic University of the Sacred Heart, Rome, Italy. 24 Department of Geriatrics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. 25 Geriatria, Accettazione geriatrica e Centro di ricerca per l'Invecchiamento, Italian National Research Center on Aging (INRCA), Ancona, Italy. 26 University of Luxembourg, Ezch-sur-Alzette, Luxembourg. 27 AZ Alma, Eeklo, Belgium. 28 Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain. 29 Landspitali University Hospital, Reykjavik, Iceland. 30 Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 31 Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy. 32 Department of Geriatric Medicine, Cork University Hospital, Cork, Ireland. 33 Department of Medicine, University College Cork, Cork, Ireland. 34 Academic Department of Geriatric Medicine, Brighton and Sussex Medical School, Brighton, Sussex, UK. 35 Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany. 36 Institute of Hygiene and Clinical Epidemiology, University Hospital of Udine, Udine, Italy. 37 Department of Elderly Medicine, Brighton and Sussex University Hospitals NHS Trust, Sussex, UK. 38 Institute of Clinical Pharmacology Mannheim, University of Heidelberg, Heidelberg, Germany. 39 Department of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands. 40 Department of Epidemiology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.en_US
dc.identifier.journalDrugs and agingen_US
dc.rights.accessNational Consortium - Landsaðganguren_US
dc.departmentcodeGER12
dc.source.journaltitleDrugs & aging


This item appears in the following Collection(s)

Show simple item record